Trial intelligence / Profile preview

Inhaled insulin in pediatric type 1 diabetes

NCT00567775Phase 2Completed

Sponsor
Novo Nordisk
Start
Oct 2002
Primary completion
Nov 2002
Modality
Biologic
Countries
1
01

Overview

A Phase 2 trial of insulin human in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Oct 2002; status: completed.

02

Drugs

insulin human
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00567775.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00567775.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call